USP22 can exert its cancer-promoting effect by upregulating the nicotinamide phosphoribosyltransferase (NAMPT)/SIRT1, AKT and ERK signaling pathways involved with c-Myc activation (Liu H. et al., 2019; Zhang K. et al., 2019). This evidence concerns the gene NAMPT and cancer.